Wessels, A. M. A., Elzinga, F. A., Koppelman, G. H., Akkerman, O. W., Mian, P., & Touw, D. J. (2025). Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1258, 124604. https://doi.org/10.1016/j.jchromb.2025.124604
Citace podle Chicago (17th ed.)Wessels, A. Mireille A., Femke A. Elzinga, Gerard H. Koppelman, Onno W. Akkerman, Paola Mian, a Daan J. Touw. "Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and Their Active Metabolites in Plasma Using UHPLC-MS/MS: Doors Open to the Application of Therapeutic Drug Monitoring in Cystic Fibrosis Treatment." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1258 (2025): 124604. https://doi.org/10.1016/j.jchromb.2025.124604.
Citace podle MLA (9th ed.)Wessels, A. Mireille A., et al. "Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and Their Active Metabolites in Plasma Using UHPLC-MS/MS: Doors Open to the Application of Therapeutic Drug Monitoring in Cystic Fibrosis Treatment." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol. 1258, 2025, p. 124604, https://doi.org/10.1016/j.jchromb.2025.124604.